-
FDA Advisory Committees To Consider Risks And Benefits, If Any, Of Avandia At July 30 Meeting
July 2007 Cochrane Review Of Trials Contends That Avandia Is No Better Than Other Diabetes Drugs While Being Associated With Serious Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) On July 30, 2007 the…
-
Improvements Needed For Reporting And Evaluating Adverse Drug Reactions In Order To Find Safety Signals
How Widespread Media Coverage, Increased Data Mining Opportunities, And Online Postings By Doctors Can Give Rise To So-Called False Positives (Posted by Tom Lamb at DrugInjuryWatch.com) The most recent headlines about Avandia are indicative…
-
The Adverse Drug Reactions And Medication Errors That Require Hospital Care Most Often
Some Lessons Learned From A "Top 10" Drug Errors Session At The American Pharmacists Association 2007 Annual Meeting (Posted by Tom Lamb at DrugInjuryWatch.com) The American Pharmacists Association (APhA) Annual Meeting was held in…
-
Latest Avandia Heart Risk Findings Reported In July 5, 2007 NEJM Edition
Avandia Seems Associated With Increased Rate Of Heart Failure; Less Clear Whether Glaxo’s Diabetes Drug Causes Heart Attacks, Other Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) In the July 5, 2007 edition of…
-
Black-Box Warning About Anaphylaxis Being Put On Asthma Drug Xolair
Potentially Deadly Allergic Reaction Occurs Twice As Often As Previously Stated On Medication's Prior Label (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA announced on July 2, 2007 that the package insert, or label,…
